ClinicalTrials.gg
Status unknownNCT03989648Updated Aug 31, 2021

Adequacy of Exsanguination Between Esmarch Bandages and Simple Leg Elevation in Total Knee Arthroplasty

An interventional study of Esmarch bandages and simple leg elevation in Esmarch Bandages and Simple Leg Elevation, sponsored by Navamindradhiraj University. Status unknown at 1 site in Thailand. Per ClinicalTrials.gov, last updated 2021-08-31.

Sponsored by Navamindradhiraj University · Not applicable, Interventional, and Treatment

How we know

The sponsor has not verified this record recently (last verified Aug 2021), so the status shown — last known as Active, not recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Sex
All
01

Study summary

To compare the adequacy of exsanguination in the surgical field between the use of the Esmarch bandages elevation and the simple leg elevation.

02

Conditions studied

  • Esmarch Bandages
  • Simple Leg Elevation
03

In context

Lead sponsor

Navamindradhiraj University is the lead sponsor of 14 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Primary osteoarthritis of knee

Exclusion criteria

Exclusion Criteria:

  • There are deep vein thrombosis and pulmonary embolism
  • There are bleeding disorder,hypercoagulability,peripheral arterial disease and chronic venous insufficiency
  • Take blood clotting pills
  • Have had total knee arthroplasty
  • > 30
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Active comparator
    Esmarch bandages

    Other: Esmarch bandages

  • Active comparator
    simple leg elevation

    Other: simple leg elevation

Interventions

  • OtherEsmarch bandages

    Esmarch bandage (also known as Esmarch's bandage for surgical haemostasis or Esmarch's tourniquet) in its modern form is a narrow (5 to 10 cm wide) soft rubber bandage that is used to expel venous blood from a limb (exsanguinate) that has had its arterial supply cut off by a tourniquet.

  • Othersimple leg elevation

    simple leg elevation 45 degree for 2 minutes is used to expel venous blood from a limb

06

What researchers measure

Primary outcomes

  1. Fromme-Boezaart surgical field scale

    Fromme-Boezaart surgical field scale is visual assessment of surgical field using a 6-point scale (min=0, max=5) 0 mean No bleeding 1. mean Slight bleeding ; no suctioning of blood required 2. mean Slight bleeding ; occasional suctioning required. Surgical field not threatened 3. mean Slight bleeding ; frequent suctioning required. Bleeding threatens surgical filed a few seconds after suction is removed 4. mean Moderate bleeding ; frequent suctioning required. Bleeding threatens surgical field directly after suction is removed 5. mean Severe bleeding ; constant suctioning required. Bleeding appears faster than can be removed by suction. Surgical field severely threatened and surgery not possible 0=best possible operating conditions and dryness of the surgical field; 5= worst possible conditions

    Time frame: Immediate after surgery

Secondary outcomes

  1. Numerical rating scale: NRS at 24 hrs

    NRS is a pain intensity assessment of patients using a 11 point scale (min=0, max=10) 0=no pain 10= worst pain

    Time frame: 24 hours after surgery

  2. Numerical rating scale: NRS at 72 hrs

    NRS is a pain intensity assessment of patients using a 11 point scale (min=0, max=10) 0=no pain 10= worst pain

    Time frame: 72 hours after surgery

07

Study locations

1 site
  • Navamindradhiraj University
    Dusit, Bangkok 10300, Thailand
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2019 (actual). Primary completion is estimated for Feb 2022, 32 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 14, 2019
First posted
Jun 18, 2019
StartActual
Jun 1, 2019
Primary completionEst.
Feb 1, 2022
CompletionEst.
Dec 2022
Last update
Aug 31, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 31, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03989648
Lead sponsor
Navamindradhiraj University
Responsible party
Satit Thiengwittayaporn (Associate Professor, Navamindradhiraj University) — Principal investigator
First posted
Jun 18, 2019
Start date
Jun 1, 2019
Primary completion
Feb 1, 2022 (estimated)
Completion
Dec 2022 (estimated)
Last update
Aug 31, 2021

Study contacts

Satit Thiengwittayaporn, M.D.
principal investigator · Department of Orthopaedics, Faculty of Medicine Vajira Hospital, Navamindradhiraj University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion